Richard N Formica

13PUBLICATIONS
37CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 14, 2026
Placing Organ Allocation Out of Sequence in the Proper Context.

Richard N Formica

|Mar 25, 2024
Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians.

Alexander Wiseman, Tarek Alhamad, Rita R Alloway

|Feb 03, 2023
It Is Time for Patient-Reported Outcome Measures to Be Included in the Approval Process for Solid Organ Transplant Medications.

Richard N Formica, Nicole Turgeon

|Jan 31, 2023
The Unintended Consequences of Changes to the Organ Allocation Policy.

Richard N Formica, Jesse D Schold

|Oct 04, 2022
Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients: Results of the CTOT-19 Trial.

Donald E Hricik, Brian Armstrong, Tarek Alhamad

|Aug 30, 2022
Blood Transcriptomes of SARS-CoV-2-Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity.

Zeguo Sun, Zhongyang Zhang, Khadija Banu

Pageof 3

Frequent Collaborators

2 joint publications

Madhav C Menon

2 joint publications

Tarek Alhamad

2 joint publications

Darren Stewart

2 joint publications

Alexander Wiseman